US Patent 10583109 Use of silver(I) complexes as anticancer agents

Patent 10583109 was granted and assigned to University of Johannesburg on March, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

University of Johannesburg

Current Assignee

University of Johannesburg

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10583109

Date of Patent

March 10, 2020

Patent Application Number

15590767

Date Filed

May 9, 2017

Patent Primary Examiner

‌

Paul W Dickinson

Patent abstract

The present invention relates to the use of silver(I) monophosphine complexes as Active Pharmaceutical Ingredients (API's), including anticancer agents, for the treatment, diagnosis and/or prevention of cancer. The present invention also relates to pharmaceutical compositions containing such complexes and further extends to a method of treating or diagnosing a subject/patient suffering from cancer.